Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported)

June 13, 2012

 

 

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-31553   36-4459170

(State or Other Jurisdiction

of Incorporation)

  (Commission File No.)  

(IRS Employer

Identification No.)

20 South Wacker Drive

Chicago, Illinois 60606

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (312) 930-1000

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07. Submission of Matters to a Vote of Security Holders.

CME Group Inc. (the “Company”) held its Annual Meeting on May 23, 2012 (the “Annual Meeting”). The results of the Annual Meeting were reported on a Current Report, filed with the SEC on May 29, 2012, and the Company disclosed that the election of five members of the Class B-3 Nominating Committee to serve until 2013 from a slate of ten nominees (elected by the Class B-3 shareholders) was deferred to June 13, 2012 at 12:00 p.m. at 20 South Wacker Drive, Chicago, Illinois. The following are the results from the deferred proposal:

The election of five members of the Class B-3 Nominating Committee to serve until 2013 from a slate of ten nominees (elected by the Class B-3 shareholders):

 

Name

   Votes For      Votes Against      Abstentions  

J. Kenny Carlin

     155         51         208   

Bryan P. Cooley

     150         38         226   

Laurence E. Dooley

     116         49         249   

Mario J. Florio

     101         52         261   

Christopher P. Gaffney

     160         45         209   

David P. Gaughan

     112         42         260   

Glen D. Kohn

     92         46         276   

Peter J. Kosanovich

     68         56         290   

Carl A. Maniscalco

     100         54         260   

Steven E. Wollack

     146         35         233   


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    CME Group Inc.
  Registrant
Date: June 19, 2012   By:  

/s/ Kathleen M. Cronin

  Name:   Kathleen M. Cronin
  Title:  

Senior Managing Director, General

Counsel and Corporate Secretary